E. Burnett

发表

dogs with hemophilia A Efficacy and safety of a new-class hemostatic drug candidate, AV513, in

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2013 .

Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A.

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2008, Blood.

Efficacy and Safety of a New-Class of Hemostatic Drug Candidate , AV 513 , in Hemophilia A Dogs

Kirk W. Johnson, D. Lillicrap, A. Labelle, 2007 .

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response.

P. Thompson, D. Lillicrap, C. Hough, 2009, Blood.

cytokine production to favor a Th1 response by a regulatory CD4+CD25+-dependent mechanism and by shifting Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice

D. Lillicrap, C. Hough, A. Labelle, 2013 .

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 (cid:1) CD25 (cid:1) -dependent mechanism and by shifting cytokine production to favor a Th1 response

P. Thompson, D. Lillicrap, C. Hough, 2008 .

cytokine production to favor a Th 1 response-dependent mechanism and by shifting + CD 25 + by a regulatory CD 4 Anti-CD 3 prevents factor VIII inhibitor development in hemophilia A mice

P. Thompson, D. Lillicrap, C. Hough, 2008 .

Immunoglobulin isotypes and functional anti‐FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice

M. Othman, D. Lillicrap, C. Hough, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.

L. Naldini, M. Ozelo, B. Brown, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice.

M. Othman, D. Lillicrap, C. Hough, 2009, Blood.

Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models.

D. Lillicrap, Kate Sponagle, C. Notley, 2011, Blood.